Shareholding for the Period Ended December 31, 2017
Bafna Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here18-01-2018
18-01-2018
Statement Of Investor Complaints For The Quarter Dec 2017
Certificate on investor compliant as per regulation 13(3) of SEBI (LODR), Regulations, 2015 of Bafna Pharmaceuticals Limited for the period ended 31 December 2017 for your records.17-01-2018
Updates
Intimation of the petition filed against the Company under Sec 9 Rule 6 of the Insolvency and Bankruptcy Code, 2016 by M/s. Encore Healthcare Private Ltd.05-12-2017
Meeting Updates
We wish to clarify the following; In the Outcome of the Board meeting submitted on 10th November, 2017, we have intimated the appointment of Ms. Nirmala L, as the Company Secretary. The effective date of appointment was inadvertently mentioned as 23.10.2017 (the Offer letter date) instead of 10.11.2017. The Effective date of appointment of the Company Secretary is 10th November 2017.27-11-2017
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Bafna Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here15-11-2017
Financial Results For Quarter Ended September 2017
The Unaudited financial results for the quarter and half year ended 30 September 2017 in the prescribed format in compliance with Reg 33 of the SEBI (Listing Obligation and Disclosure Requirements), Regulations, 201510-11-2017
Appointment of Company Secretary / Compliance Officer
The Board of Directors in their meeting held on 10 November 2017 has appointed Ms. Nirmala L, as the Company Secretary and Compliance Officer of the Company with effect from 23 October 2017.10-11-2017
Outcome of Board Meeting
The Board of Directors of the Company in their meeting held today the 10th day of November, 2017 which commenced at 3.30 PM and concluded at 6.00 PM, inter alia transacted the following: 1.Considered and approved Unaudited Financial Statements for the quarter and Half year ended 30th September, 2017 2.Appointment of Ms. Nirmala as Company Secretary of the Company (Brief Profile attached)10-11-2017
22Nd AGM Voting Results
AGM Voting Results - All the resolutions were passed with requisite majority.06-11-2017
22Nd AGM Voting Results
AGM Voting Results - All the resolutions were passed with requisite majority.06-11-2017